Led by Prof Joel Tarning, Clinical Pharmacology conducts its own research and supports the MORU Tropical Health Network and external research groups with study design, drug measurements, pharmacometric analysis and interpretation of pharmacological results.
Clinical Pharmacology is led by Prof Joel Tarning.
Dr Richard Hoglund is Head of Pharmacometrics. Established a pharmacometric research group in 2007 focusing on pharmacokinetic and pharmacodynamic modelling to further our understanding of infectious disease pharmacology, Pharmacometrics conducts non-compartmental analysis and nonlinear mixed-effects modelling on a population basis. This research has already had a major influence on the currently recommended treatment regimens for malaria
Head of Laboratory Dr Markus Winterberg leads the Bioanalysis and Biochemistry & Discovery teams. Established in 2014, Biochemistry & Discovery focuses on metabolomic, proteomic and lipidomic research. By combining high-resolution/high-accuracy measurements with the isotopic pattern, molecular formulas can be generated with high confidence. This state of the art capability provides an essential tool in developing improved diagnostics, understanding pathophysiology, better treatment, discovering mechanisms of drug action and resistance, and new drug development.
In addition, the MORU Clinical Pharmacology Department has an active, successful postgraduate student programme. If you’re interested in doing a postgraduate degree with us, have a look at MORU’s Students page. Then, contact one of our principal investigators for a potential supervisor or Prof Stuart Blacksell, Post-Graduate Student Coordinator.